Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Operating Expenses (2020 - 2025)

Rapid Micro Biosystems' Operating Expenses history spans 6 years, with the latest figure at $19.2 million for Q3 2025.

  • For Q3 2025, Operating Expenses fell 2.2% year-over-year to $19.2 million; the TTM value through Sep 2025 reached $75.9 million, down 2.71%, while the annual FY2024 figure was $78.0 million, 1.41% down from the prior year.
  • Operating Expenses for Q3 2025 was $19.2 million at Rapid Micro Biosystems, down from $19.4 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $21.6 million in Q4 2022 and bottomed at $14.7 million in Q1 2021.
  • The 5-year median for Operating Expenses is $19.4 million (2025), against an average of $19.2 million.
  • The largest annual shift saw Operating Expenses surged 1265.92% in 2021 before it dropped 14.37% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $19.8 million in 2021, then rose by 9.46% to $21.6 million in 2022, then decreased by 14.37% to $18.5 million in 2023, then decreased by 0.42% to $18.4 million in 2024, then grew by 4.14% to $19.2 million in 2025.
  • Per Business Quant, the three most recent readings for RPID's Operating Expenses are $19.2 million (Q3 2025), $19.4 million (Q2 2025), and $18.9 million (Q1 2025).